Quantum Genesis AI Corp.
QTZMAbout the company
Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name to Quantum Genesis AI Corp. in February 2026.
Investment snapshot
Positive
0
BUY / PASS
Neutral / negative
0 / 2
NEUTRAL / FAIL
Median fair value
—
No comparable estimates
Models with upside
0 / 2
Positive margin of safety
Key risk
No clean pass — all 2 investors flag at least one profitability criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Piotroski F-Score | Sleep Scale Economies Shared |
|---|---|---|
| Verdict | FAIL | FAIL |
| Score | ||
| Analysis | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A |
| Margin of Safety | N/A | N/A |
| Financial Basis | Annual history · FY 2025 Latest source filing: 2025-11-13 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2025-11-13 Score computed: 2026-11-14 |
Where It Passes
Where It Falls Short
- Profitability0% pass✓ 1✗ 4▾
No clean pass — all 2 investors flag at least one profitability criterion
Net Income / Total Assets-34121.40%✗PiotroskiROA > 0ROA Change YoY-1785.69% -> -34121.40% (delta: -32335.71%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=-21435.10%, ROA=-34121.40%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY✗PiotroskiImproved YoYRevenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holding - Cash Flow0% pass✓ 1✗ 2▾
No clean pass — all 2 investors flag at least one cash flow criterion
Operating Cash Flow$-0.1M✗PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=-21435.10%, ROA=-34121.40%✓PiotroskiCFO/Assets > ROAPositive Operating Cash Flow frequency0/5 years positive✗SleepPositive OCF in >= 70% of available years - Efficiency0% pass✗ 3▾
All 2 investors flag QTZM's efficiency
Current Ratio Change YoY0.03 -> 0.00✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.00x -> 0.00x✗PiotroskiImproved YoYROIC (5-year)0/2 years above 12% (latest -280.7%)✗SleepROIC > 12% in a majority of years - Verdicts0% pass✗ 2▾
Unanimous FAIL across all 2 scored lenses
Overall verdict✗PiotroskiFAIL (F-Score 2)✗SleepFAIL (0/6)
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Issued 12.0% of shares last year.
- Buybacks
- —
- Dividends
- —
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-04-30 2025-05-01 – 2026-04-30 Sources · derived quarter valuesDerived from cumulative filings: revenue, net income, pre tax income, interest expense, operating cash flow. | Q3 FY 2026 2026-02-01 – 2026-04-30 Sources · derived quarter valuesDerived from cumulative filings: net income, interest expense, operating cash flow. | Q2 FY 2026 2025-11-01 – 2026-01-31 Sources · derived quarter valuesDerived from cumulative filings: interest expense, operating cash flow. | Q1 FY 2026 2025-08-01 – 2025-10-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2018Sources
| FY 2017Sources
|
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | -- | $93.5K↓27% | $128.1K |
| Operating Income | -- | -$19.1K | -$1.4K | -$39.2K | -$180.5K↓10% | -$163.6K | -- | -- | -- |
| Net Income | -$4.4M | -$24.9K↑62% | -$4.3M | -$49.9K | -$199.3K↓12% | -$178.6K | -- | -$28.2K↑14% | -$32.9K |
| EPS (Diluted) | -- | $0.00 | $-0.12 | $0.00 | $-0.01 | $-0.01 | -- | $0.00 | $0.00 |
| Gross Margin | — | — | — | — | — | — | — | 4.5%↓74% | 17.4% |
| Operating Margin | — | — | — | — | — | — | — | — | — |
| ROE | 1002.3% | — | — | — | 45.2%↓28% | 63.0% | — | 330.4%↑280% | -183.1% |
| Total Debt | $251.2K | $251.2K↑4% | $232.1K | $537.2K | $491.5K↑50% | $328.7K | -- | -- | -- |
| Shareholders' Equity | -$443.3K | -$443.3K↓10% | -$418.3K | -$490.6K | -$440.7K↓56% | -$283.3K↓171% | -$104.7K | -$8.5K↓148% | $17.9K |
| Current Ratio | 0.00 | 0.00↓91% | 0.00 | 0.00 | 0.00↓96% | 0.03 | — | — | 74.48 |
| Debt / Equity | -0.57 | -0.57↑5% | -0.55 | -1.09 | -1.12↑4% | -1.16 | — | — | — |
| Operating Cash Flow | -$71.6K | -$19.1K | -$23.9K | -$19.9K | -$125.2K↓23% | -$101.6K | -- | -$2.7K↑93% | -$38.1K |
| Free Cash Flow | -- | -- | -- | -- | -- | -- | -- | -$14.6K | -- |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Chemicals
QTZM vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EIDP, Inc.CTA-PB | $46.8B | $54.21 | — | — | — | — | — | — | 2/9 | 5/9 | 2/7 | 0/3 | F-Score 1 | 4/11 |
| CF Industries Holdings, Inc.CF | $18.3B | $125.09 | $7.1B | $1.8B | 37.2% | 0.66 | 32.5% | 3.37 | 3/9 | 4/9 | 5/7 | 3/3 | F-Score 8 | 8/11 |
| RPM INTERNATIONAL INC/DE/RPM | $13.2B | $103.73 | $7.9B | $661.4M | 20.0% | 0.77 | — | 1.68 | 3/9 | 2/9 | 3/7 | 1/3 | F-Score 6 | 7/11 |
| Element Solutions IncESI | $8.0B | $33.08 | $2.6B | $190.8M | 7.1% | 0.61 | 13.4% | 3.68 | 2/9 | 2/9 | 1/7 | 1/3 | F-Score 5 | 6/11 |
| NEWMARKET CORPNEU | $6.5B | $709.19 | $2.7B | $418.7M | 23.5% | 0.50 | 20.0% | 2.53 | 4/9 | 6/9 | 2/7 | 1/3 | F-Score 5 | 5/11 |
| HEXCEL CORP /DE/HXL | $6.0B | $79.46 | $1.9B | $109.4M | 8.7% | 0.79 | 9.1% | 2.26 | 2/9 | 2/9 | 3/7 | 0/3 | F-Score 6 | 4/11 |
| ICL Group Ltd.ICL | $5.8B | $4.52 | $7.2B | $226.0M | 3.8% | 0.46 | 8.1% | 1.33 | 5/9 | 4/9 | 2/7 | 0/3 | F-Score 4 | 5/11 |
| BALCHEM CORPBCPC | $5.5B | $173.14 | $1.0B | $154.8M | 12.3% | 0.13 | 20.2% | 2.07 | 2/9 | 4/9 | 2/7 | 1/3 | F-Score 9 | 5/11 |